Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
Sponsor: Guangzhou Burning Rock Dx Co., Ltd.
Summary
PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.
Official title: A Prospective Multi-canceR Early-detection and interVENTional Study in Asymptomatic Individuals: PREVENT
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
12500
Start Date
2022-06-01
Completion Date
2028-12-31
Last Updated
2022-07-06
Healthy Volunteers
Yes
Interventions
OverC multi-cancer detection blood test
Blood collection for the OverC multi-cancer detection blood test and standard-of-care screening with return of results
Locations (1)
West China Hospital, Sichuan University
Chengdu, Sichuan, China